14.20
-0.48
(-3.27%)
At close: April 17 at 5:31:31 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
47,271
47,271
-29,843
-37,359
-43,510
Investing Cash Flow
-18,044
-18,044
-3,932
69
1,563
Financing Cash Flow
-171
-171
13,993
46,022
23,150
End Cash Position
30,370
30,370
1,353
21,208
12,411
Capital Expenditure
-23,743
-23,743
-3,956
-15
-34
Issuance of Capital Stock
18,820
18,820
511
20,353
901
Issuance of Debt
7,500
7,500
33,000
35,792
24,559
Repayment of Debt
-25,475
-25,475
-18,446
-3,500
--
Repurchase of Capital Stock
--
--
--
-56
-922
Free Cash Flow
23,528
23,528
-33,799
-37,374
-43,544
12/31/2020 - 11/3/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDIA.SW Idorsia Ltd
1.1400
+1.42%
MOLN.SW Molecular Partners AG
3.1600
-3.66%
NWRN.SW Newron Pharmaceuticals S.p.A.
6.46
+0.62%
BION.SW BB Biotech AG
26.55
-0.93%
CUV.AX Clinuvel Pharmaceuticals Limited
10.85
+1.40%
ADXN.SW Addex Therapeutics Ltd
0.0500
0.00%
CELUW Celularity Inc.
0.0400
0.00%
RLF.SW Relief Therapeutics Holding SA
2.5500
+2.41%
BSLN.SW Basilea Pharmaceutica AG
41.30
-0.96%
ATXS Astria Therapeutics, Inc.
4.0400
+1.51%